These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21810100)

  • 41. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic detection of human immunodeficiency virus (HIV) by nucleic acid amplification test in a frequent platelet donor during the pre-seroconversion period.
    Pondé RA
    Arch Virol; 2011 Nov; 156(11):2085-90. PubMed ID: 21842160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
    Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
    Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).
    O'Riordan J; Williams P; Donnellan J
    Vox Sang; 2005 Nov; 89(4):266. PubMed ID: 16262763
    [No Abstract]   [Full Text] [Related]  

  • 47. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of HCV-NAT assays and experience with NAT application for blood screening in Germany.
    Nübling CM; Chudy M; Löwer J
    Biologicals; 1999 Dec; 27(4):291-4. PubMed ID: 10686055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.
    Lee S; Hu J; Tang S; Wood O; Francis K; Machuca A; Rios M; Daniel S; Vockley C; Awazi B; Zekeng L; Hewlett I
    J Med Virol; 2006; 78 Suppl 1():S22-3. PubMed ID: 16622873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A collaborative study to establish the first National Standard for HIV-1 RNA nucleic acid amplification techniques (NAT) in Taiwan.
    Yang YC; Yang-Chih Shih D; Tsai MH; Cheng CH; Cheng HF; Lo CF; Wang DY
    J Virol Methods; 2013 Aug; 191(2):122-7. PubMed ID: 23608407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection.
    Ethridge SF; Wesolowski LG; Nasrullah M; Kennedy MS; Delaney KP; Candal D; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S63-6. PubMed ID: 21995932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.
    Drosten C; Seifried E; Roth WK
    J Clin Microbiol; 2001 Dec; 39(12):4302-8. PubMed ID: 11724836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests.
    Glaubitz J; Sizmann D; Simon CO; Hoffmann KS; Drogan D; Hesse M; Lang G; Kroeh M; Simmler P; Dewald M; Haberhausen G; Lindauer A; Beyser K; Reber A; Baumeister A; Wolf E; Jaeger H; Babiel R
    J Clin Virol; 2011 Feb; 50(2):119-24. PubMed ID: 21109484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.